Filter News
Area of Research
News Type
News Topics
- (-) Biomedical (20)
- (-) Computer Science (51)
- (-) Cybersecurity (4)
- (-) Decarbonization (16)
- (-) Energy Storage (19)
- (-) Isotopes (17)
- (-) Mercury (2)
- (-) Neutron Science (33)
- (-) Space Exploration (5)
- (-) Transportation (17)
- 3-D Printing/Advanced Manufacturing (34)
- Advanced Reactors (9)
- Artificial Intelligence (27)
- Big Data (12)
- Bioenergy (22)
- Biology (14)
- Biotechnology (6)
- Buildings (9)
- Chemical Sciences (14)
- Clean Water (2)
- Climate Change (13)
- Composites (4)
- Coronavirus (20)
- Critical Materials (5)
- Education (1)
- Emergency (1)
- Environment (32)
- Exascale Computing (9)
- Fossil Energy (2)
- Frontier (6)
- Fusion (16)
- Grid (9)
- High-Performance Computing (14)
- Machine Learning (11)
- Materials (13)
- Materials Science (41)
- Mathematics (4)
- Microelectronics (1)
- Microscopy (9)
- Molten Salt (1)
- Nanotechnology (15)
- National Security (13)
- Net Zero (4)
- Nuclear Energy (31)
- Partnerships (12)
- Physics (19)
- Polymers (7)
- Quantum Computing (9)
- Quantum Science (24)
- Security (5)
- Simulation (9)
- Statistics (2)
- Summit (18)
- Sustainable Energy (26)
- Transformational Challenge Reactor (5)
Media Contacts
As ORNL’s fuel properties technical lead for the U.S. Department of Energy’s Co-Optimization of Fuel and Engines, or Co-Optima, initiative, Jim Szybist has been on a quest for the past few years to identify the most significant indicators for predicting how a fuel will perform in engines designed for light-duty vehicles such as passenger cars and pickup trucks.
Six ORNL scientists have been elected as fellows to the American Association for the Advancement of Science, or AAAS.
The University of Texas at San Antonio (UTSA) has formally launched the Cybersecurity Manufacturing Innovation Institute (CyManII), a $111 million public-private partnership.
A multi-institutional team, led by a group of investigators at Oak Ridge National Laboratory, has been studying various SARS-CoV-2 protein targets, including the virus’s main protease. The feat has earned the team a finalist nomination for the Association of Computing Machinery, or ACM, Gordon Bell Special Prize for High Performance Computing-Based COVID-19 Research.
Experiments led by researchers at ORNL have determined that several hepatitis C drugs can inhibit the SARS-CoV-2 main protease, a crucial protein enzyme that enables the novel coronavirus to reproduce.
ORNL and three partnering institutions have received $4.2 million over three years to apply artificial intelligence to the advancement of complex systems in which human decision making could be enhanced via technology.
ORNL has added 10 virtual tours to its campus map, each with multiple views to show floor plans, rotating dollhouse views and 360-degree navigation. As a user travels through a map, pop-out informational windows deliver facts, videos, graphics and links to other related content.
NellOne Therapeutics has licensed a drug delivery system from the Department of Energy’s Oak Ridge National Laboratory that is designed to transport therapeutics directly to cells infected by SARS-CoV-2, the virus causing COVID-19.
When Sandra Davern looks to the future, she sees individualized isotopes sent into the body with a specific target: cancer cells.
There are more than 17 million veterans in the United States, and approximately half rely on the Department of Veterans Affairs for their healthcare.